Antagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating Autophagy

Cell Reports

Volumn 13, Issue 4, 2015, Pages 771-782

  Kim, Changyoun ^a,b   Rockenstein, Edward ^b   Spencer, Brian ^b   Kim, Hyung Koo ^a   Adame, Anthony ^b   Trejo, Margarita ^b   Stafa, Klodjan ^b   Lee, He Jin ^c   Lee, Seung Jae ^a   Masliah, Eliezer ^b  

^a Seoul National University College of Medicine   (South Korea)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Konkuk University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; TOLL LIKE RECEPTOR 2; MTOR PROTEIN, HUMAN; ONCOPROTEIN; TARGET OF RAPAMYCIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGY; BIOACCUMULATION; CONTROLLED STUDY; IN VITRO STUDY; MOTOR DYSFUNCTION; MOUSE; NERVE CELL; NERVE DEGENERATION; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SYNUCLEINOPATHY; ANIMAL; DEFICIENCY; GENETICS; KNOCKOUT MOUSE; METABOLISM; NEURODEGENERATIVE DISEASES; PHYSIOLOGY; TRANSGENIC MOUSE;

ALPHA-SYNUCLEIN; ANIMALS; AUTOPHAGY; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NEURODEGENERATIVE DISEASES; ONCOGENE PROTEIN V-AKT; TOLL-LIKE RECEPTOR 2; TOR SERINE-THREONINE KINASES;

EID: 84945546570     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.09.044     Document Type: Article

References (41)

1. Bae E.J., Yang N.Y., Song M., Lee C.S., Lee J.S., Jung B.C., Lee H.J., Kim S., Masliah E., Sardi S.P., Lee S.J. Glucocerebrosidase depletion enhances cell-to-cell transmission of α-synuclein. Nat. Commun. 2014, 5:4755.
2. Braak H., Del Tredici K. Invited Article: Nervous system pathology in sporadic Parkinson disease. Neurology 2008, 70:1916-1925.
3. Cameron J.S., Alexopoulou L., Sloane J.A., DiBernardo A.B., Ma Y., Kosaras B., Flavell R., Strittmatter S.M., Volpe J., Sidman R., Vartanian T. Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals. J. Neurosci. 2007, 27:13033-13041.
4. Chen C.Y., Lin C.W., Chang C.Y., Jiang S.T., Hsueh Y.P. Sarm1, a negative regulator of innate immunity, interacts with syndecan-2 and regulates neuronal morphology. J. Cell Biol. 2011, 193:769-784.
5. Clough R.L., Stefanis L. A novel pathway for transcriptional regulation of alpha-synuclein. FASEB J. 2007, 21:596-607.
6. Delgado M.A., Deretic V. Toll-like receptors in control of immunological autophagy. Cell Death Differ. 2009, 16:976-983.
7. Delgado M.A., Elmaoued R.A., Davis A.S., Kyei G., Deretic V. Toll-like receptors control autophagy. EMBO J. 2008, 27:1110-1121.
8. Hirsch E.C., Hunot S. Neuroinflammation in Parkinson's disease: a target for neuroprotection?. Lancet Neurol. 2009, 8:382-397.
9. Janku F., McConkey D.J., Hong D.S., Kurzrock R. Autophagy as a target for anticancer therapy. Nat. Rev. Clin. Oncol. 2011, 8:528-539.
10. Kim C., Lee S.J. Controlling the mass action of alpha-synuclein in Parkinson's disease. J. Neurochem. 2008, 107:303-316.
11. Kim C., Ho D.H., Suk J.E., You S., Michael S., Kang J., Joong Lee S., Masliah E., Hwang D., Lee H.J., Lee S.J. Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat. Commun. 2013, 4:1562.
12. Kiselyov K., Jennigs J.J., Rbaibi Y., Chu C.T. Autophagy, mitochondria and cell death in lysosomal storage diseases. Autophagy 2007, 3:259-262.
13. Lafon M., Megret F., Lafage M., Prehaud C. The innate immune facet of brain: human neurons express TLR-3 and sense viral dsRNA. J. Mol. Neurosci. 2006, 29:185-194.
14. Lee H.J., Lee S.J. Characterization of cytoplasmic alpha-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells. J. Biol. Chem. 2002, 277:48976-48983.
15. Lee H.J., Khoshaghideh F., Patel S., Lee S.J. Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway. J. Neurosci. 2004, 24:1888-1896.
16. Lee H.J., Suk J.E., Lee K.W., Park S.H., Blumbergs P.C., Gai W.P., Lee S.J. Transmission of Synucleinopathies in the Enteric Nervous System of A53T Alpha-Synuclein Transgenic Mice. Exp. Neurobiol. 2011, 20:181-188.
17. Lee H.J., Bae E.J., Lee S.J. Extracellular α--synuclein-a novel and crucial factor in Lewy body diseases. Nat. Rev. Neurol. 2014, 10:92-98.
18. Leng Y., Chuang D.M. Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity. J. Neurosci. 2006, 26:7502-7512.
19. Leow-Dyke S., Allen C., Denes A., Nilsson O., Maysami S., Bowie A.G., Rothwell N.J., Pinteaux E. Neuronal Toll-like receptor 4 signaling induces brain endothelial activation and neutrophil transmigration in vitro. J. Neuroinflammation 2012, 9:230.
20. Letiembre M., Liu Y., Walter S., Hao W., Pfander T., Wrede A., Schulz-Schaeffer W., Fassbender K. Screening of innate immune receptors in neurodegenerative diseases: a similar pattern. Neurobiol. Aging 2009, 30:759-768.
21. Liu H.Y., Hong Y.F., Huang C.M., Chen C.Y., Huang T.N., Hsueh Y.P. TLR7 negatively regulates dendrite outgrowth through the Myd88-c-Fos-IL-6 pathway. J. Neurosci. 2013, 33:11479-11493.
22. Liu H.Y., Chen C.Y., Hsueh Y.P. Innate immune responses regulate morphogenesis and degeneration: roles of Toll-like receptors and Sarm1 in neurons. Neurosci. Bull. 2014, 30:645-654.
23. Long-Smith C.M., Sullivan A.M., Nolan Y.M. The influence of microglia on the pathogenesis of Parkinson's disease. Prog. Neurobiol. 2009, 89:277-287.
24. Ma Y., Li J., Chiu I., Wang Y., Sloane J.A., Lü J., Kosaras B., Sidman R.L., Volpe J.J., Vartanian T. Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis. J. Cell Biol. 2006, 175:209-215.
25. Maries E., Dass B., Collier T.J., Kordower J.H., Steece-Collier K. The role of alpha-synuclein in Parkinson's disease: insights from animal models. Nat. Rev. Neurosci. 2003, 4:727-738.
26. Mash D.C., Ouyang Q., Pablo J., Basile M., Izenwasser S., Lieberman A., Perrin R.J. Cocaine abusers have an overexpression of alpha-synuclein in dopamine neurons. J. Neurosci. 2003, 23:2564-2571.
27. Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., Sagara Y., Sisk A., Mucke L. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 2000, 287:1265-1269.
28. McCann H., Stevens C.H., Cartwright H., Halliday G.M. α-Synucleinopathy phenotypes. Parkinsonism Relat. Disord. 2014, 20(Suppl 1):S62-S67.
29. Menzies F.M., Garcia-Arencibia M., Imarisio S., O'Sullivan N.C., Ricketts T., Kent B.A., Rao M.V., Lam W., Green-Thompson Z.W., Nixon R.A., et al. Calpain inhibition mediates autophagy-dependent protection against polyglutamine toxicity. Cell Death Differ. 2015, 22:433-444.
30. Okun E., Griffioen K.J., Mattson M.P. Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci. 2011, 34:269-281.
31. Ravikumar B., Vacher C., Berger Z., Davies J.E., Luo S., Oroz L.G., Scaravilli F., Easton D.F., Duden R., O'Kane C.J., Rubinsztein D.C. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 2004, 36:585-595.
32. Rockenstein E., Mallory M., Hashimoto M., Song D., Shults C.W., Lang I., Masliah E. Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters. J. Neurosci. Res. 2002, 68:568-578.
33. Sahani M.H., Itakura E., Mizushima N. Expression of the autophagy substrate SQSTM1/p62 is restored during prolonged starvation depending on transcriptional upregulation and autophagy-derived amino acids. Autophagy 2014, 10:431-441.
34. Sarkar S., Floto R.A., Berger Z., Imarisio S., Cordenier A., Pasco M., Cook L.J., Rubinsztein D.C. Lithium induces autophagy by inhibiting inositol monophosphatase. J. Cell Biol. 2005, 170:1101-1111.
35. Sarkar S., Davies J.E., Huang Z., Tunnacliffe A., Rubinsztein D.C. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J. Biol. Chem. 2007, 282:5641-5652.
36. Schmitz F., Heit A., Dreher S., Eisenächer K., Mages J., Haas T., Krug A., Janssen K.P., Kirschning C.J., Wagner H. Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells. Eur. J. Immunol. 2008, 38:2981-2992.
37. Spencer B., Emadi S., Desplats P., Eleuteri S., Michael S., Kosberg K., Shen J., Rockenstein E., Patrick C., Adame A., et al. ESCRT-mediated uptake and degradation of brain-targeted α-synuclein single chain antibody attenuates neuronal degeneration in vivo. Mol. Ther. 2014, 22:1753-1767.
38. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., Takeda K., Akira S. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999, 11:443-451.
39. Tang S.C., Arumugam T.V., Xu X., Cheng A., Mughal M.R., Jo D.G., Lathia J.D., Siler D.A., Chigurupati S., Ouyang X., et al. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc. Natl. Acad. Sci. USA 2007, 104:13798-13803.
40. Valera E., Mante M., Anderson S., Rockenstein E., Masliah E. Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson's disease. J. Neuroinflammation 2015, 12:93.
41. Webb J.L., Ravikumar B., Atkins J., Skepper J.N., Rubinsztein D.C. Alpha-Synuclein is degraded by both autophagy and the proteasome. J. Biol. Chem. 2003, 278:25009-25013.